SELESTE UPSHAW: Open Payments
NPI 1710542717 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$911 in 15 payments from 12 companies in 2025. Trend: 2023 $1,638 · 2024 $888 · 2025 $911
Food & beverage: $911
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $151 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Abbott Laboratories | 1 | $76 |
| GENZYME CORPORATION | 1 | $65 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Exact Sciences Corporation | 1 | $19 |
Products named: MOUNJARO, XIFAXAN, Leqembi, COBENFY, Auvelity, FREESTYLE LIBRE 3, SPRAVATO, REXULTI.
Industry payments across VA — which companies pay providers there.
